 |
The Journal of Neuroscience, January 12, 2005, 25(2):372-383; doi:10.1523/JNEUROSCI.4035-04.2005
Previous Article | Next Article 
Neurobiology of Disease
Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia
Takanori Hashimoto,1
Sarah E. Bergen,2
Quyen L. Nguyen,2
Baoji Xu,4
Lisa M. Monteggia,5
Joseph N. Pierri,1
Zhuoxin Sun,3
Allan R. Sampson,3 and
David A. Lewis1,2
Departments of 1Psychiatry, 2Neuroscience, and 3Statistics, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, 4Department of Pharmacology, Georgetown University Medical School, Washington, DC 20057, and 5Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390
Dysfunction of inhibitory neurons in the prefrontal cortex (PFC), represented by decreased expression of GABA-related genes such as the 67 kDa isoform of glutamate decarboxylase (GAD67) and parvalbumin (PV), appears to contribute to cognitive deficits in subjects with schizophrenia. We investigated the involvement of signaling mediated by brain-derived neurotrophic factor (BDNF) and its receptor tyrosine kinase TrkB in producing the altered GABA-related gene expression in schizophrenia. In 15 pairs of subjects with schizophrenia and matched control subjects, both BDNF and TrkB mRNA levels, as assessed by in situ hybridization, were significantly decreased in the PFC of the subjects with schizophrenia, whereas the levels of mRNA encoding the receptor tyrosine kinase for neurotrophin-3, TrkC, were unchanged. In this cohort, within-pair changes in TrkB mRNA levels were significantly correlated with those in both GAD67 and PV mRNA levels. Decreased BDNF, TrkB, and GAD67 mRNA levels were replicated in a second cohort of 12 subject pairs. In the combined cohorts, the correlation between within-pair changes in TrkB and GAD67 mRNA levels was significantly stronger than the correlation between the changes in BDNF and GAD67 mRNA levels. Neither BDNF nor TrkB mRNA levels were changed in the PFC of monkeys after a long-term exposure to haloperidol. Genetically introduced decreases in TrkB expression, but not in BDNF expression, also resulted in decreased GAD67 and PV mRNA levels in the PFC of adult mice; in addition, the cellular pattern of altered GAD67 mRNA expression paralleled that present in schizophrenia. Decreased TrkB signaling appears to underlie the dysfunction of inhibitory neurons in the PFC of subjects with schizophrenia.
Key words: cortex; GABA; GAD; in situ hybridization; parvalbumin; postmortem; trkB hypomorphic
Received June 8, 2004;
revised November 18, 2004;
accepted November 18, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
J. G. Maldonado-Aviles, A. A. Curley, T. Hashimoto, A. L. Morrow, A. J. Ramsey, P. O'Donnell, D. W. Volk, and D. A. Lewis
Altered Markers of Tonic Inhibition in the Dorsolateral Prefrontal Cortex of Subjects With Schizophrenia
Am J Psychiatry,
April 1, 2009;
166(4):
450 - 459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Lewis, R. Y. Cho, C. S. Carter, K. Eklund, S. Forster, M. A. Kelly, and D. Montrose
Subunit-Selective Modulation of GABA Type A Receptor Neurotransmission and Cognition in Schizophrenia
Am J Psychiatry,
December 1, 2008;
165(12):
1585 - 1593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Y. Tseng, B. L. Lewis, T. Hashimoto, S. R. Sesack, M. Kloc, D. A. Lewis, and P. O'Donnell
A Neonatal Ventral Hippocampal Lesion Causes Functional Deficits in Adult Prefrontal Cortical Interneurons
J. Neurosci.,
November 26, 2008;
28(48):
12691 - 12699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mellios, H.-S. Huang, A. Grigorenko, E. Rogaev, and S. Akbarian
A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex
Hum. Mol. Genet.,
October 1, 2008;
17(19):
3030 - 3042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Eggan, T. Hashimoto, and D. A. Lewis
Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
Arch Gen Psychiatry,
July 1, 2008;
65(7):
772 - 784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Morris, T. Hashimoto, and D. A. Lewis
Alterations in Somatostatin mRNA Expression in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia or Schizoaffective Disorder
Cereb Cortex,
July 1, 2008;
18(7):
1575 - 1587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hashimoto, H. H. Bazmi, K. Mirnics, Q. Wu, A. R. Sampson, and D. A. Lewis
Conserved Regional Patterns of GABA-Related Transcript Expression in the Neocortex of Subjects With Schizophrenia
Am J Psychiatry,
April 1, 2008;
165(4):
479 - 489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hashimoto and D. A. Lewis
BDNF Val66Met Polymorphism and GAD67 mRNA Expression in the Prefrontal Cortex of Subjects With Schizophrenia
Am J Psychiatry,
March 1, 2006;
163(3):
534 - 537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. H. Woo and B. Lu
Regulation of Cortical Interneurons by Neurotrophins: From Development to Cognitive Disorders
Neuroscientist,
February 1, 2006;
12(1):
43 - 56.
[Abstract]
[PDF]
|
 |
|
|

|